ClinicalTrials.Veeva

Menu

Integrative Treatment Methods in COVID-19

A

Amasya University

Status

Completed

Conditions

COVID-19
Patient Experience
Health Attitude

Treatments

Other: focus interview

Study type

Observational

Funder types

Other

Identifiers

NCT05089578
Amasya U-2

Details and patient eligibility

About

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Full description

This study was a qualitative type of phenomenological study conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. The study was completed with 12 people. The data were collected between July and October 2021. The interviews lasted for an average of 25-30 minutes. The data collected with the semi-structured interview form were analyzed by descriptive content analysis method after the interviews were over.

Enrollment

12 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • individuals who underwent Covid-19 and used any of the integrative treatment methods
  • agreed to participate in the study constituted the sample group.

Exclusion criteria

Trial design

12 participants in 1 patient group

Individuals with Covid-19
Description:
Interviews were conducted with individuals who had Covid-19, and their experiences with the integrative methods they used were determined.
Treatment:
Other: focus interview

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems